Notable Labs Ltd (NAS:NTBL)
$ 0.8 -0.01 (-1.23%) Market Cap: 7.21 Mil Enterprise Value: 967,000.00 PE Ratio: 0 PB Ratio: 0.48 GF Score: 18/100

Q2 2021 Vascular Biogenics Ltd Earnings Call Transcript

Aug 16, 2021 / 12:30PM GMT
Operator

Greetings. Welcome to VBL Therapeutics Second Quarter 2021 Financial Results and Update Call. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to the VBL team. Thank you. You may begin.

Unidentified Company Representative

Thank you. Good morning, everyone, and thank you for joining today's VBL Therapeutics Second Quarter 2021 Financial Results and Corporate Update. Leading the call will be Professor Dror Harats, Chief Executive Officer; and Amos Ron, Chief Financial Officer. A press release of the company's financial results was issued earlier this morning and is available on the Investor Relations page of the company's website at vblrx.com.

Before turning the call over to management, I would like to remind everyone that during the conference call, forward-looking statements made by management are intended to fall within the Safe Harbor Provisions Act of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934 as amended. As set forth in our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot